Date published: 2026-3-3

1-800-457-3801

SCBT Portrait Logo
Seach Input

OR9I1 Inhibitors

OR9I1 inhibitors are a class of chemical compounds specifically designed to target and inhibit the activity of the olfactory receptor 9I1 (OR9I1), a member of the large family of G protein-coupled receptors (GPCRs) involved in the detection of odorants. Olfactory receptors like OR9I1 are primarily expressed in the sensory neurons of the olfactory epithelium, where they bind to volatile chemical compounds in the environment, initiating a signaling cascade that ultimately leads to the perception of smell. OR9I1, in particular, is one of the many receptors that contribute to the complex sense of olfaction by recognizing specific molecular structures of odorants. The inhibition of OR9I1 disrupts its ability to detect and respond to its specific odorant ligands, providing a means to study the function and significance of this receptor in olfactory signaling. The development and study of OR9I1 inhibitors involve detailed investigations into the receptor's structure and the molecular mechanisms by which these inhibitors exert their effects. These compounds are typically designed to bind to the active site or other critical regions of OR9I1, preventing the receptor from interacting with its natural odorant ligands or from undergoing the conformational changes necessary for signal transduction. By inhibiting OR9I1, researchers can explore the specific role of this receptor within the broader olfactory system, including how it contributes to the detection of specific scents and how its activity integrates with the signals from other olfactory receptors. Additionally, OR9I1 inhibitors are valuable tools for studying the general principles of GPCR function and olfactory transduction, offering insights into how sensory information is processed and translated into neural signals. Through these studies, scientists can gain a deeper understanding of the molecular underpinnings of smell and the intricate receptor networks that make olfaction one of the most complex and nuanced senses in mammals.

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

Trichostatin A inhibits histone deacetylases, leading to increased histone acetylation, which could open up chromatin and result in the decreased transcription of OR9I1.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

5-Azacytidine inhibits DNA methyltransferases, potentially reducing DNA methylation at the OR9I1 gene locus, which could lead to a decrease in its mRNA and protein expression.

Valproic Acid

99-66-1sc-213144
10 g
$87.00
9
(1)

By inhibiting histone deacetylases, Valproic Acid may enhance histone acetylation, potentially leading to a reduction in OR9I1 gene transcription levels.

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$133.00
$275.00
37
(2)

Suberoylanilide Hydroxamic Acid′s inhibition of histone deacetylases could decrease the transcription efficiency of the OR9I1 gene by altering chromatin accessibility.

Sodium Butyrate

156-54-7sc-202341
sc-202341B
sc-202341A
sc-202341C
250 mg
5 g
25 g
500 g
$31.00
$47.00
$84.00
$222.00
19
(3)

Sodium Butyrate, through its histone deacetylase inhibition, may promote histone acetylation, potentially leading to reduced transcriptional activity of the OR9I1 gene.

Mithramycin A

18378-89-7sc-200909
1 mg
$55.00
6
(1)

Mithramycin A binds to DNA, potentially obstructing transcription factor access and RNA polymerase activity at the OR9I1 gene, leading to reduced RNA synthesis.

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$74.00
$243.00
$731.00
$2572.00
$21848.00
53
(3)

Actinomycin D intercalates into DNA and blocks RNA polymerase, potentially leading to a significant decrease in OR9I1 mRNA synthesis and subsequent protein production.

RG 108

48208-26-0sc-204235
sc-204235A
10 mg
50 mg
$131.00
$515.00
2
(1)

RG 108 reduces DNA methylation by inhibiting DNA methyltransferases, potentially leading to the decreased expression of methylation-silenced genes such as OR9I1.

5-Aza-2′-Deoxycytidine

2353-33-5sc-202424
sc-202424A
sc-202424B
25 mg
100 mg
250 mg
$218.00
$322.00
$426.00
7
(1)

5-Aza-2′-Deoxycytidine, by demethylating DNA, could decrease methylation at the OR9I1 gene promoter, potentially leading to a reduction in gene expression.

MS-275

209783-80-2sc-279455
sc-279455A
sc-279455B
1 mg
5 mg
25 mg
$24.00
$90.00
$212.00
24
(2)

Through the inhibition of class I histone deacetylases, MS-275 may lead to decreased transcriptional activity of the OR9I1 gene by modifying chromatin states.